Systemic Candidiasis in Mice: New Insights From an Old Model

Animal models are essential to understand the pathophysiology of infections, to test novel antifungal compounds, and to determine the potential of adjunctive therapies, e.g. immune modulation. The murine model of systemic candidiasis induced by intravenous infection is technically straightforward, highly reproducible, and well-characterized. However, intravenous inoculation circumvents the necessity for the fungus to translocate across mucosal barriers, and the use of SPF mice that are immunologically naïve to Candida does not reflect the situation in human patients, in whom adaptive immune responses have been induced by mucosal colonization prior to infection. Therefore, mouse models that combine intestinal colonization and systemic infection have been developed, resulting in novel insights into host-fungal interactions and immunity. In this review, we summarize the main findings, current questions, and discuss how these might impact the translatability of results from mice to humans.

[1]  B. Jungnickel,et al.  Functionality of the human antibody response to Candida albicans , 2021, Virulence.

[2]  Ryan M. O’Connell,et al.  Adaptive immunity induces mutualism between commensal eukaryotes , 2021, Nature.

[3]  P. Pappas,et al.  Candidemia and Invasive Candidiasis. , 2021, Infectious disease clinics of North America.

[4]  A. Puel,et al.  Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies , 2021, Cell.

[5]  Kerstin Hünniger,et al.  Significant Differences in Host-Pathogen Interactions Between Murine and Human Whole Blood , 2021, Frontiers in Immunology.

[6]  Alistair J. P. Brown,et al.  The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives , 2020, FEMS microbiology reviews.

[7]  Rebecca A. Ward,et al.  The first line of defense: effector pathways of anti-fungal innate immunity. , 2020, Current opinion in microbiology.

[8]  H. Seifert,et al.  Attributable mortality of candidemia after introduction of echinocandins , 2020, Mycoses.

[9]  S. Gaffen,et al.  Regulation of host-microbe interactions at oral mucosal barriers by type 17 immunity , 2020, Science Immunology.

[10]  G. Butler,et al.  High-resolution mycobiota analysis reveals dynamic intestinal translocation prior to invasive candidiasis , 2019, Nature Medicine.

[11]  Irina Leonardi,et al.  Gut Mycobiota in Immunity and Inflammatory Disease. , 2019, Immunity.

[12]  Irina Leonardi,et al.  Profound mycobiome differences between segregated mouse colonies do not influence Th17 responses to a newly introduced gut fungal commensal. , 2019, Fungal genetics and biology : FG & B.

[13]  A. Scheffold,et al.  Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans , 2019, Cell.

[14]  Tony T. Jiang,et al.  Commensal Candida albicans Positively Calibrates Systemic Th17 Immunological Responses. , 2019, Cell host & microbe.

[15]  D. Artis,et al.  Response to Fungal Dysbiosis by Gut-Resident CX3CR1+ Mononuclear Phagocytes Aggravates Allergic Airway Disease. , 2018, Cell host & microbe.

[16]  Ghee Chuan Lai,et al.  Experimental evolution of a fungal pathogen into a gut symbiont , 2018, Science.

[17]  D. Underhill,et al.  Expansion of commensal fungus Wallemia mellicola in the gastrointestinal mycobiota enhances the severity of allergic airway disease in mice , 2018, PLoS pathogens.

[18]  S. Seyedmousavi,et al.  Fungal infections in animals: a patchwork of different situations. , 2018, Medical mycology.

[19]  D. McGovern,et al.  CX3CR1+ mononuclear phagocytes control immunity to intestinal fungi , 2018, Science.

[20]  Tony T. Jiang,et al.  Commensal Fungi Recapitulate the Protective Benefits of Intestinal Bacteria. , 2017, Cell host & microbe.

[21]  R. Gibbs,et al.  The gut mycobiome of the Human Microbiome Project healthy cohort , 2017, Microbiome.

[22]  A. Pitarch,et al.  Serum Antibody Profile during Colonization of the Mouse Gut by Candida albicans: Relevance for Protection during Systemic Infection. , 2017, Journal of proteome research.

[23]  S. Gaffen,et al.  The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney , 2016, PLoS pathogens.

[24]  M. Bauer,et al.  Immunoproteomic Analysis of Antibody Responses to Extracellular Proteins of Candida albicans Revealing the Importance of Glycosylation for Antigen Recognition. , 2016, Journal of proteome research.

[25]  D. Underhill,et al.  Immunological Consequences of Intestinal Fungal Dysbiosis. , 2016, Cell host & microbe.

[26]  Changying Jiang,et al.  Dectin-3 Deficiency Promotes Colitis Development due to Impaired Antifungal Innate Immune Responses in the Gut , 2016, PLoS pathogens.

[27]  G. Núñez,et al.  Gut Microbiota-Induced Immunoglobulin G Controls Systemic Infection by Symbiotic Bacteria and Pathogens. , 2016, Immunity.

[28]  Manuel A. S. Santos,et al.  Fungal Chitin Induces Trained Immunity in Human Monocytes during Cross-talk of the Host with Saccharomyces cerevisiae* , 2016, The Journal of Biological Chemistry.

[29]  Alistair J. P. Brown,et al.  Candida albicans colonization and dissemination from the murine gastrointestinal tract: the influence of morphology and Th17 immunity , 2014, Cellular microbiology.

[30]  R. Xavier,et al.  Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity , 2014, Science.

[31]  R. Xavier,et al.  mTOR- and HIF-1α–mediated aerobic glycolysis as metabolic basis for trained immunity , 2014, Science.

[32]  D. Pittet,et al.  Candida colonization index and subsequent infection in critically ill surgical patients: 20 years later , 2014, Intensive Care Medicine.

[33]  J. Guinea.  Global trends in the distribution of Candida species causing candidemia. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[34]  S. Leibundgut-Landmann,et al.  IL-17 regulates systemic fungal immunity by controlling the functional competence of NK cells. , 2014, Immunity.

[35]  A. Koh.  Murine Models of Candida Gastrointestinal Colonization and Dissemination , 2013, Eukaryotic Cell.

[36]  G. Huffnagle,et al.  The emerging world of the fungal microbiome. , 2013, Trends in microbiology.

[37]  M. Metsis,et al.  Characterization of the Vaginal Micro- and Mycobiome in Asymptomatic Reproductive-Age Estonian Women , 2013, PloS one.

[38]  D. MacCallum.  Mouse model of invasive fungal infection. , 2013, Methods in molecular biology.

[39]  V. Young,et al.  Candida albicans and Bacterial Microbiota Interactions in the Cecum during Recolonization following Broad-Spectrum Antibiotic Therapy , 2012, Infection and Immunity.

[40]  A. Macpherson,et al.  Interactions Between the Microbiota and the Immune System , 2012, Science.

[41]  M. Dubinsky,et al.  Interactions Between Commensal Fungi and the C-Type Lectin Receptor Dectin-1 Influence Colitis , 2012, Science.

[42]  S. Brunke,et al.  Candida albicans dimorphism as a therapeutic target , 2012, Expert review of anti-infective therapy.

[43]  D. MacCallum,et al.  The contribution of mouse models to our understanding of systemic candidiasis. , 2011, FEMS microbiology letters.

[44]  Patrick M. Gillevet,et al.  Characterization of the Oral Fungal Microbiome (Mycobiome) in Healthy Individuals , 2010, PLoS pathogens.

[45]  A. Levin,et al.  Candida colonisation as a source for candidaemia. , 2009, The Journal of hospital infection.

[46]  G. Pier,et al.  Mucosal Damage and Neutropenia Are Required for Candida albicans Dissemination , 2008, PLoS pathogens.

[47]  A. Schoepfer,et al.  Anti‐Saccharomyces cerevisiae mannan antibodies (ASCA) of Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans , 2007, Inflammatory bowel diseases.

[48]  K. McCoy,et al.  Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. , 2007, Seminars in immunology.

[49]  C. Nombela,et al.  Decoding Serological Response to Candida Cell Wall Immunome into Novel Diagnostic, Prognostic, and Therapeutic Candidates for Systemic Candidiasis by Proteomic and Bioinformatic Analyses* , 2006, Molecular & Cellular Proteomics.

[50]  D. MacCallum,et al.  Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice , 2005, Mycoses.

[51]  T. Umenai,et al.  Systemic candidiasis fromCandida albicans colonizing the gastrointestinal tract of mice , 1979, Experientia.

[52]  P. Schwarzenberger,et al.  Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. , 2004, The Journal of infectious diseases.

[53]  J. Regadera,et al.  Sustained gastrointestinal colonization and systemic dissemination by Candida albicans, Candida tropicalis and Candida parapsilosis in adult mice. , 2000, Diagnostic microbiology and infectious disease.

[54]  E Balish,et al.  B cell knockout mice are resistant to mucosal and systemic candidiasis of endogenous origin but susceptible to experimental systemic candidiasis. , 1996, The Journal of infectious diseases.

[55]  E Balish,et al.  Acquired immunity to systemic candidiasis in immunodeficient mice. , 1991, The Journal of infectious diseases.

[56]  T. Ray.  Systemic candidiasis. , 1989, Dermatologic clinics.